{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:59:51Z","timestamp":1781333991853,"version":"3.54.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,7,22]],"date-time":"2003-07-22T00:00:00Z","timestamp":1058832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p><jats:bold>Objectives:<\/jats:bold> The aim of the first Nordic mantle cell lymphoma (MCL) protocol was to study the clinical significance of an augmented CHOP induction chemotherapy followed by high\u2010dose chemotherapy and autologous stem cell transplantation (ASCT) and to examine the prognostic significance of stem cell contamination rates in newly diagnosed patients with MCL.<\/jats:p><jats:p><jats:bold>Patients and methods:<\/jats:bold> Forty\u2010one newly diagnosed patients below 66\u2003yr were enrolled and given three series of an augmented CHOP regimen. Responders underwent stem cell mobilization with a fourth course of CHOP, stem cell harvest and ASCT. Stem cell purging was optional in the protocol and followed the routine of each participating centre. The number of tumour cells in the reinfused autografts was estimated by flow cytometry or quantitative PCR.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Induction therapy led to complete remission (CR) in 11 of 41 patients (27%), partial remission (PR) in 20 of 41 patients (49%) and no response in nine patients (22%), whereas one patient was not evaluable. Twenty\u2010seven of the 31 responders underwent ASCT and 24 achieved or maintained a CR. The overall and failure\u2010free 4\u2010yr survival on intention\u2010to\u2010treat basis were 51% and 15%, respectively. Among the transplanted patients, a significantly increased failure\u2010free (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.03) and overall survival (<jats:italic>P<\/jats:italic>\u2003=\u20030.03) was noted among patients transplanted in CR compared with PR, respectively. By contrast, reinfusion of highly variable numbers of tumour cells with the autografts (range 0.71\u201380\u2003\u00d7\u200310<jats:sup>6<\/jats:sup> tumour cells), did not affect outcome.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In MCL, an important strategy to improve the outcome will be to intensify the induction chemotherapy.<\/jats:p>","DOI":"10.1034\/j.1600-0609.2003.00093.x","type":"journal-article","created":{"date-parts":[[2003,7,22]],"date-time":"2003-07-22T16:10:48Z","timestamp":1058890248000},"page":"73-80","source":"Crossref","is-referenced-by-count":69,"title":["Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant"],"prefix":"10.1111","volume":"71","author":[{"given":"Niels S.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki","family":"Elonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaarle","family":"Franssila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Langholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ralfki\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5ns","family":"\u00c5kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Nordic Lymphoma Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,22]]},"reference":[{"key":"e_1_2_24_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_24_3_2","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma \u2013 an entity comes of age","volume":"87","author":"Weisenburger DD","year":"1996","journal-title":"Blood"},{"key":"e_1_2_24_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075"},{"key":"e_1_2_24_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.13"},{"key":"e_1_2_24_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.12.3803"},{"key":"e_1_2_24_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701400"},{"key":"e_1_2_24_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702135"},{"key":"e_1_2_24_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04140.x"},{"key":"e_1_2_24_10_2","first-page":"861","article-title":"Myeloablative radiochemotherapy followed by autologous stem cell transplantation leads to a significant prolongation of event\u2010free survival in patients with mantle cell lymphoma (MCL). Results of a prospective randomized European intergroup study","volume":"98","author":"Hiddemann W","year":"2002","journal-title":"Blood"},{"key":"e_1_2_24_11_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008380527502"},{"key":"e_1_2_24_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92560-G"},{"key":"e_1_2_24_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111283252201"},{"key":"e_1_2_24_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.4212"},{"key":"e_1_2_24_15_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V89.2.724","article-title":"Molecular monitoring of minimal residual disease in follicular and mantle cell non\u2010Hodgkin's lymphomas treated with high\u2010dose chemotherapy and peripheral blood progenitor cell autografting","volume":"89","author":"Corradini P","year":"1997","journal-title":"Blood"},{"key":"e_1_2_24_16_2","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V88.6.2228.bloodjournal8862228","article-title":"Eradication of polymerase chain reaction\u2010detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation","volume":"88","author":"Provan D","year":"1996","journal-title":"Blood"},{"key":"e_1_2_24_17_2","first-page":"321","article-title":"Accurate quantitation of residual B\u2010precursor acute lymphoblastic leukemia by limiting dilution and a PCR\u2010based detection system: a description of the method and the principles involved [see comments]","volume":"9","author":"Ouspenskaia MV","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_24_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.5.1922"},{"key":"e_1_2_24_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00366-5"},{"key":"e_1_2_24_20_2","first-page":"750","article-title":"The impact of early stem cell transplantation on the prognosis of mantle cell lymphoma","volume":"95","author":"Dreger P","year":"2000","journal-title":"Blood"},{"key":"e_1_2_24_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402406"},{"key":"e_1_2_24_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900070505"},{"key":"e_1_2_24_23_2","first-page":"1858","article-title":"Multicenter phase III trial to evaluate CD34+ selection versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma","volume":"93","author":"Vescio R","year":"2000","journal-title":"Blood"},{"key":"e_1_2_24_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701637"},{"key":"e_1_2_24_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.864"},{"key":"e_1_2_24_26_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008309405678"},{"key":"e_1_2_24_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00028-X"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2003.00093.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2003.00093.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0609.2003.00093.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:30:01Z","timestamp":1697229001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0609.2003.00093.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,22]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1034\/j.1600-0609.2003.00093.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0609.2003.00093.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,22]]}}}